Chief Scientists

Binglinag Chen, Ph.D. Chief Scientist in Drug Discovery in Innovent Biologics and has been working at Innovent Bio. since beginning of 2016. He used to work at Bristol-Myers Squibb before join the Innovent Bio. He was responsible for pharmacology in immunotherapy and cell surface receptor anticancer drug. It is one of the earliest patents for BMS in 2006 to develop methods of antibody drug of Nivolumab (PD-1) and one of inventor of PD-1 in BMS. Before in BMS has served in Bayer at Berkeley California to develop anticancer drug was charge of Pharmacology